Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | BCL2 | P10415 | 3/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8294162 | 0.96 | ADRB3 (0.45) | ADRB3ADRA2BADRA2CPOLBBCL2 | |
| SCHEMBL8279027 | 0.94 | ADRB3 (0.48) | ADRB3ADRA2BADRA2CPOLBBCL2 | |
| SCHEMBL3974750 | 0.94 | ADRB3 (0.48) | ADRB3ADRA2BADRA2CPOLBBCL2 | |
| SCHEMBL3974753 | 0.94 | ADRB3 (0.48) | ADRB3ADRA2BADRA2CPOLBBCL2 | |
| SCHEMBL8294158 | 0.94 | ADRB3 (0.47) | ADRB3ADRA2BADRA2CPOLBBCL2 | |
| SCHEMBL4212063 | 0.91 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CPOLB | |
| SCHEMBL4212067 | 0.91 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CPOLB | |
| SCHEMBL13610357 | 0.91 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CPOLB | |
| SCHEMBL8279038 | 0.91 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CPOLB | |
| SCHEMBL3969647 | 0.91 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1680137-B1 | Macrocyclic carboxylic acid and acylsulfonamide compound as inhibitor of HCV replication | HOFFMANN LA ROCHE (CH) | 2012-11-21 | — | — | EP | disclosed |